Street Takeaways - CMS 2026 ESRD rate proposal; implications for FME.GR and DVA (€40.94, -1.21)
CMS publishes rate proposal for end stage renal disease bundle payment (24-Jun, timing uncertain)
Fresenius Medical Care downgraded to hold from buy at Metzler Capital Markets (€41.26, 0.00)
Powered by FactSet Research Systems Inc.